| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 22.05.
| InterMune agrees to sell immune drug Actimmune | | 5 | Yahoo-USA |
| 22.05.
| InterMune to Sell Actimmune Rights | | 3 | Zacks |
| 22.05.
| InterMune signs deal with Vidara Therapeutics to divest Actimmune | | 3 | Pharma Bus Review |
| 21.05.
| InterMune To Divest Actimmune For $55 Mln In Cash Plus Two-year Royalty Stream | | 65 | AFX News |
| WASHINGTON (dpa-AFX) - InterMune Inc. (ITMN) announced that it has reached a
definitive agreement with Vidara Therapeutics International Limited to sell its
rights to Actimmune (interferon...
Mehr lesen zu:
InterMune To Divest Actimmune For $55 Mln In Cash Plus Two-year Royalty Stream | |
| 21.05.
| Intermune Will Divest Rights to Vidara for $55M in Cash, Plus 2 Year Royalty Stream | | - | Benzinga.com |
| 21.05.
| InterMune to Divest Actimmune® (Interferon Gamma-1b) | | 40 | PR Newswire |
| BRISBANE, Calif., May 21, 2012 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced that it has reached a definitive agreement with Vidara Therapeutics International Limited (Vidara) to...
Mehr lesen zu:
InterMune to Divest Actimmune® (Interferon Gamma-1b) | |
| 09.05.
| InterMune had the Lowest Relative Performance in the Healthcare Sector | | 10 | SmarTrend |
| 07.05.
| Has InterMune Become the Perfect Stock? | | 16 | Motley Fool |
| 04.05.
| InterMune Bearish Moving Average Crossover Alert | | 8 | SmarTrend |
| 30.04.
| Esbriet Drives InterMune's Revenue | | 7 | Zacks |
| 27.04.
| InterMune Makes a Move: Down 13.2% | | 2 | SmarTrend |
| 27.04.
| Downgrade Alert for InterMune | | 9 | SmarTrend |
| 27.04.
| Intermune Q1 Net Loss Widens | | 104 | AFX News |
| WASHINGTON (dpa-AFX) - Intermune, Inc. (ITMN) reported a first-quarter net
loss of $47.6 million or $0.74 per share, wider than the net loss of $32.1
million or $0.57 per share last year.On...
Mehr lesen zu:
Intermune Q1 Net Loss Widens | |
| 26.04.
| InterMune Reports First Quarter 2012 Financial Results And Business Highlights | | 55 | PR Newswire |
| BRISBANE, Calif., April 26, 2012 /PRNewswire/ --InterMune, Inc. (Nasdaq: ITMN) today announced results from operations for the first quarter ended March 31, 2012.InterMune also highlighted its recent...
Mehr lesen zu:
InterMune Reports First Quarter 2012 Financial Results And Business Highlights | |
| 24.04.
| Bearish Moving Average Cross by InterMune | | 1 | SmarTrend |
| 19.04.
| InterMune To Release First Quarter Financial Results On April 26 | | 57 | PR Newswire |
| BRISBANE, Calif., April 19, 2012 /PRNewswire/ --InterMune, Inc. (NASDAQ: ITMN) today announced that it will release its first quarter 2012 financial results at the close of the U.S. markets on Thursday...
Mehr lesen zu:
InterMune To Release First Quarter Financial Results On April 26 | |
| 16.04.
| Relatively Good Performance Detected in Shares of InterMune in the Healthcare Sector | | 3 | SmarTrend |
| 13.04.
| Stock Investors Sell Off Shares of InterMune, Down 5.3% | | 3 | SmarTrend |
| 09.04.
| InterMune Shares Fall After Delay in Trial of Esbriet | | 11 | SmarTrend |
| 09.04.
| InterMune Shares Tumble On Respiratory Drug Clinical Trial Delay | | 2 | SmarTrend |
